Our explorative study suggests that promoter methylation of the SPARC gene is linked to IPF but not to NIPF, and could represent a potential molecular marker of disease, thus warranting further investigations on larger cohorts. This evidence concerns the gene SPARC and idiopathic pulmonary fibrosis.